Agnostics Diagnostics
Due: November 20, 2025 The purpose of this RPP is to support the advanced development, clinical evaluation, and FDA clearance of mNGS-based diagnostic assays for viral and bacterial pathogen detection. BARDA seeks highly flexible, rapidly Read More